Yuan Weng Selected Research

Lung Diseases (Lung Disease)

8/2015

Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuan Weng Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 01/2013
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2013
3	Neoplasm Metastasis (Metastasis) 02/2020 - 07/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 07/2007
1	Carcinogenesis 01/2021
1	Lung Diseases (Lung Disease) 08/2015
1	Colonic Neoplasms (Colon Cancer) 05/2013
1	Stomach Neoplasms (Stomach Cancer) 01/2013
1	Esophageal Neoplasms (Esophageal Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2007
2	Circular RNAIBA 01/2022 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 05/2013 - 01/2013
2	SurvivinIBA 05/2013 - 01/2013
1	Biological ProductsIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 08/2015
1	DisintegrinsIBA 01/2015
1	Metalloproteases (Metalloproteinases)IBA 01/2015
1	homocamptothecinIBA 05/2013
1	hydroxycamptothecinumIBA 05/2013
1	Small Interfering RNA (siRNA)IBA 05/2013
1	alfatide IIIBA 05/2013
1	IntegrinsIBA 05/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	glutathione S-transferase T1IBA 01/2012
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2007
1	TenascinIBA 07/2007
1	Peptide Hydrolases (Proteases)FDA Link 07/2007

Therapy/Procedure

3	Therapeutics 02/2020 - 01/2013
1	Neoadjuvant Therapy 02/2020
1	Drug Therapy (Chemotherapy) 01/2013